OR WAIT null SECS
January 26, 2022
New technology serves as reminder for the appropriate uses of CRISPR.
January 19, 2022
Significant challenges still lie ahead, but several specialists and a plethora of new technologies are well positioned to gather and analyze the evidence needed for diagnosing and treating rare diseases, writes Catherine Tak Piech.
January 11, 2022
Government-led programs aim to attract scientists and offer resources to growing industry.
Oncology and rare disease are ready to reap the benefits of COVID drug development.
Growing evidence supports psychoactive substances can successfully treat mental issues.
December 09, 2021
Our annual report takes a look at pharma’s current investment in drug development, which this year demonstrates a focus on five important therapeutic areas of interest—Alzheimer’s disease, ophthalmology, NASH, anti-infectives, and opioids.
December 08, 2021
Practices to ensure accuracy in selected datasets.
October 22, 2021
Having proved its efficacy against COVID-19, mRNA technology is positioned to combat another insidious human adversary: cancer.
October 19, 2021
Leveraging RWD can lessen the strain normally put on investigators and sites.
October 12, 2021
COVID may have given real-world evidence the boost it needed to become routine, especially in areas that demand research innovation and advancement.
